Khiron Life Sciences Stock Performance
| KHRNF Stock | USD 0.01 0.00 0.00% |
The company secures a Beta (Market Risk) of 1.0, which conveys possible diversification benefits within a given portfolio. Khiron Life returns are very sensitive to returns on the market. As the market goes up or down, Khiron Life is expected to follow. Khiron Life Sciences right now secures a risk of 10.73%. Please verify Khiron Life Sciences total risk alpha and the relationship between the value at risk and day median price , to decide if Khiron Life Sciences will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Khiron Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, Khiron Life may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
| Begin Period Cash Flow | 21.6 M | |
| Total Cashflows From Investing Activities | -2.1 M |
Khiron |
Khiron Life Relative Risk vs. Return Landscape
If you would invest 1.20 in Khiron Life Sciences on January 25, 2024 and sell it today you would lose (0.30) from holding Khiron Life Sciences or give up 25.0% of portfolio value over 90 days. Khiron Life Sciences is currently producing 0.1054% returns and takes up 10.7282% volatility of returns over 90 trading days. Put another way, 95% of traded pink sheets are less volatile than Khiron, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Khiron Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Khiron Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Khiron Life Sciences, and traders can use it to determine the average amount a Khiron Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0098
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | KHRNF |
| Negative Returns |
Estimated Market Risk
| 10.73 actual daily | 95 95% of assets are less volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Khiron Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Khiron Life by adding Khiron Life to a well-diversified portfolio.
Khiron Life Fundamentals Growth
Khiron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Khiron Life, and Khiron Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Khiron Pink Sheet performance.
| Return On Equity | -0.75 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (1.90) % | |||
| Operating Margin | (1.08) % | |||
| Current Valuation | 9.19 M | |||
| Shares Outstanding | 216.39 M | |||
| Price To Book | 0.45 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 12.79 M | |||
| EBITDA | (32.03 M) | |||
| Cash And Equivalents | 5.82 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 705 K | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (20.4 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 42.27 M | |||
About Khiron Life Performance
To evaluate Khiron Life Sciences Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Khiron Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Khiron Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Khiron Life Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Khiron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.Things to note about Khiron Life Sciences performance evaluation
Checking the ongoing alerts about Khiron Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Khiron Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Khiron Life Sciences had very high historical volatility over the last 90 days | |
| Khiron Life Sciences has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 12.79 M. Net Loss for the year was (33.13 M) with profit before overhead, payroll, taxes, and interest of 6.37 M. | |
| Khiron Life Sciences has accumulated about 5.82 M in cash with (20.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Khiron Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Khiron Life's stock is overvalued or undervalued compared to its peers.
- Examining Khiron Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Khiron Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Khiron Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Khiron Life's pink sheet. These opinions can provide insight into Khiron Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Khiron Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Khiron Pink Sheet analysis
When running Khiron Life's price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |